709 Pill - white capsule/oblong, 14mm
Generic Name: miglustat
Pill with imprint 709 is White, Capsule/Oblong and has been identified as Yargesa 100 mg. It is supplied by Edenbridge Pharmaceuticals LLC.
Yargesa is used in the treatment of Gaucher Disease and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Yargesa 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 709
Yargesa
- Generic Name
- miglustat
- Imprint
- 709
- Strength
- 100 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Edenbridge Pharmaceuticals LLC
- National Drug Code (NDC)
- 42799-0709
Related images for "709"
More about Yargesa (miglustat)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
